PLGA Ester Capped (50:50), MW 5K is a low-molecular-weight biodegradable copolymer with equal amounts of lactide and glycolide. It features ester end groups and an approximate molecular weight of 5 kDa that specifically supports controlled drug delivery and biomaterial development.
Key Features and Benefits
- Ester Capped: Provides ester end groups with reduced terminal carboxyl functionality.
- 50:50 PLGA Ratio: Combines lactide and glycolide equally for versatile biodegradable formulations.
- MW 5K: Offers low molecular weight for efficient processing and flexible formulation development.
- Biodegradable: PLGA hydrolyzes into lactic acid and glycolic acid under physiological conditions.
- Versatile Polymer: Supports particles, films, matrices, coatings, and other biodegradable systems.
Applications
- Controlled Drug Delivery: Regulates drug release through biodegradable polymer matrices.
- Microparticles: Forms biodegradable microspheres and drug-loaded particles.
- Nanoparticles: Supports polymeric nanoparticles and biodegradable drug carriers.
- Polymer Formulation: Enables development of matrices, films, and controlled-release systems.
- Biomaterials: Supports coatings, scaffolds, matrices, and other biodegradable materials.
Storage and Handling
- Storage: Store at –20 °C in a sealed, dry container.
- Handling: Protect from moisture and excessive heat to minimize hydrolysis and polymer degradation.
PLGA Ester Capped (50:50), MW 5K combines low molecular weight with a balanced lactide:glycolide composition. Its ester end groups specifically support controlled drug delivery, particle formulation, and advanced biomaterial development.
AxisPharm offers 5000+ PEG Linkers with high purity. Different kinds of PEG Reagents may be available by custom synthesis.